Search Tag: Johnson & Johnson

Executive Health Management

Johnson-johnson-marks-new-era-as-global-healthcare-company-with-updated-visual-identity

2023 14 Sep

Brand and visual identity demonstrate the best of Johnson & Johnson’s care and humanity, while capturing the Company’s passion and determination to improve the health of people worldwide   For more than 135 years, Johnson & Johnson has provided health care products and solutions to people worldwide. Now, with its exclusive focus on healthcare...Read more

Executive Health Management

Johnson-johnson-to-split-into-two-companies-shares-rise

2021 12 Nov

Health-care giant Johnson & Johnson is splitting off its consumer division, following in the footsteps of other big drugmakers that have moved to focus on the more-profitable pharmaceutical market.   The consumer division will be separated in 18 to 24 months, the company said in a statement. The unit has been beset by lawsuits involving products...Read more

Executive Health Management

U-s-fda-backs-j-j-covid-19-vaccine-boosters

2021 19 Oct

On Friday, 15 October, a U.S. FDA advisory committee unanimously recommended that all adults that received the Johnson & Johnson (J&J) COVID-19 vaccine get a booster shot at least two months after their first shot. J&J now joins Pfizer and Moderna in gaining an FDA recommendation for a booster.   Unlike the Pfizer and Moderna recommendations which...Read more

Executive Health Management

Two-doses-make-johnson-johnson-covid-19-vaccine-94-effective

2021 22 Sep

In July, New York University researchers published results (Tada et. al, 2021) indicating the one-shot Johnson & Johnson (J&J) vaccine was less effective at preventing Delta variant infections. Although the study is not yet peer-reviewed, this finding is troubling given that the Delta variant now accounts for most US COVID-19 cases. Booster doses were...Read more

Executive Health Management

Emas-conclusion-on-janssen-vaccine-and-blood-clots

2021 21 Apr

The European Medicines Agency has completed its safety review for Johnson & Johnson’s COVID-19 Vaccine Janssen giving conclusions similar to those on AstraZeneca’s Vaxzevria.   You might also like: EMA announced that the single dose Covid-19 vaccine has been approved for use in individuals 18 years of age and older in the European...Read more

Executive Health Management

Vaccine-rollout-implications-of-abundance-of-caution

2021 20 Apr

Over the last week the COVID-19 vaccine landscape has once again changed drastically, with the use of J&J’s Janssen suspended in many countries and new players attracting more attention.   You might also like: Shortages of COVID-19 vaccine supplies are being felt globally, not excluding the EU and the UK. Do companies fulfil their obligations...Read more

Executive Health Management

Whats-happening-with-covid-19-vaccine-supply

2021 29 Mar

Shortages of COVID-19 vaccine supplies are being felt globally, not excluding the EU and the UK. Do companies fulfil their obligations and where will new manufacturing facilities be created?   You might also like: Why has AstraZeneca’s COVID-19 vaccine been the centre of attention in Europe over the past few days? Learn more...Read more

Executive Health Management

Eu-regulator-says-yes-to-johnson-johnson-one-shot-vaccine

2021 11 Mar

The European Medicines Agency’s (EMA) announced today that the single dose Covid-19 vaccine has been approved for use in individuals 18 years of age and older in the European Union.   Developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) in Belgium and the Netherlands, this vaccine is the fourth to be approved by the EMA....Read more

Executive Health Management

Az-covid-19-trial-continues-despite-participants-death

2020 23 Oct

This week has seen another COVID-19 vaccine-related incident: a volunteer in the AstraZeneca (AZ) vaccine trial in Brazil has died. Nevertheless, the trial continues as might the previously halted Johnson & Johnson’s (J&J) and the U.S. arm of AZ’s trial.   You might also like: Rushing COVID-19 Vaccine Development: Is It Justified?...Read more

Executive Health Management

J-js-vaccine-trial-paused

2020 13 Oct

Johnson & Johnson has announced temporarily pausing the COVID-19 vaccine candidate trials due to an unexplained illness in a study participant.   You might also like: Rushing COVID-19 Vaccine Development: Is It Justified?   As reported by STAT News, the company has informed external researchers through a document that a “passing...Read more

Executive Health Management

Lions-health-2019-creativity-and-innovation-in-healthcare

2019 26 Aug

Lions Health 2019 has offered new insights and discussions on how creativity is being embraced by the healthcare industry.   Over two days, Lions Health 2019 offered new insights and fresh ideas on how creativity can be applied to improve healthcare through focussed discussion and knowledge. This year’s agenda included first-of-its-kind creativity covering...Read more

Executive Health Management

Transforming-colorectal-surgery-outcomes

2019 26 Aug

How End to End Enhanced Recovery and Prehabilitation Transformed Colorectal Surgery Outcomes   Complications in all types of surgery place a significant burden on patients’ quality of life and on all clinicians involved in the care pathway. In laparoscopic colorectal surgery, anastomotic leaks are of great concern to surgeons and can place considerable...Read more

Cardiology Management

A-value-based-approach-to-atrial-fibrillation

2019 26 Aug

Enhancing Atrial Fibrillation Procedure Flow Garners Profound Results   One year ago, Health Management published Aiming to heal 80 percent more hearts through the power of partnership . The article outlined the bold ambitions of Oslo University Hospital – a leading center in the treatment of Atrial Fibrillation (AF) – to expand access and enhance...Read more

Executive Health Management

Outsourcing-in-clinical-trials-east-coast-2021-2

2021 25 May

POSTPONED TO 2021 DUE TO COVID-19 HEALTH CONCERNS  NEW DATES 25-26 MAY, 2021 Find Arena OCT Events on Social Media Read more

Executive Health Management

Healthcare-demands-are-growing-and-evolving-so-must-we

2018 23 May

Healthcare companies must evolve to help providers face the challenge of an ageing and growing population suffering from the increased incidence and diversity of chronic disease.   We are experiencing a paradigm shift in the demand and definition for value-based healthcare, and it is no secret that this has resulted from the daunting task that...Read more